arrow
H

Hector Bonilla

stanford university school of medicine
H指数:41
被引数:5,731

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low-Dose Aripiprazole for Long COVID Symptom Management: A Retrospective Observational Study

低剂量阿立哌唑用于长新冠症状管理:一项回顾性观察研究

2026-10-060
OAAI
Single-Cell and Plasma Proteomics Do Not Differentiate Patients With and Without SARS-CoV-2 Antigenemia in Convalescence in a Cohort of 100 Patients

单细胞和血浆蛋白质组学无法区分康复期100名患者中伴有和不伴有SARS-CoV-2抗原血症的患者。

2025-09-010
OAAI
Does long COVID in people living with HIV resemble the functional phenotype of non-HIV individuals who had moderate or severe acute COVID-19? A retrospective cross-sectional study

长期COVID在HIV感染者中是否与非HIV个体中经历过中重度急性COVID-19的功能表型相似?一项回顾性横断面研究

2025-04-250
OA
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult Study

Post-COVID-19肌痛性脑脊髓炎的发病率和患病率: 来自观察性康复-成人研究的报告

2025-01-131
OAAI
Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution

长期Covid发育、症状持续和消退的性别差异和免疫相关性

2024-11-130
OA
Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019 (COVID-19): A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
2023-03-301
OA
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
2023-03-0944
OAAI
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study

新型冠状病毒肺炎患者临床、病毒学和免疫学结局的早期免疫标志物: 一项多组学研究

2022-10-1413
OA
TNF-a+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies
2022-06-0120
OAAI
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
2022-04-2124
OAAI